Clinical Trials Sponsored by Before Brands, Inc

Total 490 results

Before Brands, Inc
Duke Clinical Research Institute

Recruiting

Infancy to Toddlerhood: Early Nutrition & Tolerance (INTENT) (INTENT)

Infant Nutrition | Diet Diversity

United States
Northwell Health
Solace Brands, Inc.

Withdrawn

The Use of Cannabinoid Patch for Knee Osteoarthritis

Osteoarthritis | Knee Osteoarthritis | CBD

United States
Tufts Medical Center
Amerifit Brands Inc

Completed

Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults

Healthy
University of South Alabama
Amerifit Brands Inc

Completed

Probiotics For The Prevention of Antibiotics Associated Diarrhea in the Pediatric Intensive Care Unit

Critical Illness | Antibiotic-associated Diarrhea
The Hillshire Brands Company
Biofortis Clinical Research, Inc.

Unknown

Effects of a Variety of Meals on Satiety

Focus of the Study is Satiety

United States
Barnes Retina Institute
QLT Inc.

Unknown

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Age-Related Macular Degeneration

United States
Barnes Retina Institute
Genentech, Inc.

Completed

Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations (PADDLE)

Retinal Vein Occlusion | Posterior Vitreous Detachment

United States
Barnes Retina Institute
Genentech, Inc.

Unknown

Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis

Presumed Ocular Histoplasmosis (POHS)

United States
RAND
Dfusion Inc.

Completed

Interventions to Improve Reproductive Health Among Adolescents

Teacher Training

United States
Johnson & Johnson Pharmaceutical Research & Development...
Bedford Research Corporation, Inc.

Completed

Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

Diabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetic Neuropathies
Hangzhou Grand Biologic Pharmaceutical, Inc.

Not yet recruiting

Efficacy and Safety of Histamine Human Immunoglobulin in the Treatment of Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria
Cephalon, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Cephalon, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Traumatic Brain Injury

United States, Germany, Italy, Spain
NuPathe Inc.

Completed

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months (NP101-008)

Migraine Disorders

United States
NuPathe Inc.

Completed

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers (NP101-006)

Migraine Disorders

United States
Cephalon, Inc.

Terminated

The Nuvigil and Provigil Pregnancy Registry

Obstructive Sleep Apnea | Narcolepsy | Shift Work Sleep Disorder

United States
Cephalon, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Traumatic Brain Injury

United States
Ware Branch
Sera Prognostics, Inc.

Terminated

Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)

Preterm Birth

United States
NuPathe Inc.

Completed

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine (NP101-007)

Migraine Disorders

United States
NuPathe Inc.

Completed

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Healthy

United States
NuPathe Inc.

Completed

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period (NP101-011)

Migraine Disorders

United States
Cephalon, Inc.

Completed

Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer

Breast Cancer

Austria, Belgium, France, Germany, Italy, Spain
Cephalon, Inc.

Terminated

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.
NCGS, Inc.

Completed

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Episodic Migraine Headache

United States
NuPathe Inc.

Completed

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Compare Bioequivalence Patches Previously Used in the NP101-007 Study

United States
NuPathe Inc.

Completed

Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

Acute Migraine
NuPathe Inc.

Completed

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months (NP101-009)

Migraine Disorders

United States
Teva Branded Pharmaceutical Products R&D, Inc.
Eisai Inc.

Completed

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

Dementia | Alzheimer's Disease

United States, Canada, Australia, South Africa
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Crohn Disease | Colitis, Ulcerative

United States, Hungary, Poland, Czechia, Japan, Belgium, Spain, Bulgaria, France, Italy, Slovakia, Austria
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

Migraine

United States, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Recruiting

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age

Migraine

United States, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age

Migraine

United States, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel (NEUGR-002)

Chemotherapy-induced Neutropenia
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With Asthma (ELIOT)

Asthma

United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Active, not recruiting

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine

Migraine

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®

Asthma

Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease (MermaiHD)

Huntington's Disease

Austria, Belgium, France, Germany, Italy, Portugal, Spain, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

Non-Hodgkin Lymphoma

China
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Bradykinesia Subscale Administered Alone Versus Regular Administration: Psychometric Properties (Bravura)

Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Fibromyalgia

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Asthma

United States, Bulgaria, Czechia, Germany, Poland
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)

Post-Traumatic Headache

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Lupus Arthritis

United States, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

Lupus Nephritis

United States, Canada, France, Russian Federation, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone® (CONFIDENCE)

Multiple Sclerosis

United States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids

Asthma

United States, Puerto Rico
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis | Hay Fever

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Non-invasive Measures of Distal Lung Disease in Asthmatics

Asthma

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique

Asthma

United States

Clinical Trials Sponsored by Before Brands, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations